Meghan McGarry • UCSF Profiles

Education and Training

Whitworth College	BS Biology	2005
University of Washington	M.D.	2009
Rainbow Babies and Children's Hospital	Pediatric Residency	2012
University of California San Francisco	Pediatric Pulmonology	2015
University of California San Francisco	Masters Clinical Research	2015

Awards and Honors

Cystic Fibrosis Foundation	2020 -	2023	K Boost Award
NHLBI	2018 -	2023	K23 Career Development Award
Cystic Fibrosis Foundation	2016 -	2019	Harry Schwachman Cystic Fibrosis Clinical Scholar
UCSF	2017		Jane Addams Social Justice Award
American Thoracic Society	2016		ATS International Conference Pediatric Abstract Scholarship
NICHD/NIGMS	2013 -	2016	Pediatric Clinical Pharmacology, Drug Action, and Pharmacogenetics T32
California Thoracic Society	2015		Best Research, Fellows Poster Presentation
Breathe California	2015		Walter Travel Grant
American Thoracic Society	2014		ATS International Conference Pediatric Abstract Scholarship
California CF Consortium	2014		Fellow’s Scholarship
California CF Consortium	2013		Fellow’s Scholarship
Rainbow Babies and Children’s Hospital	2010		Resident Teacher of the Year

Overview

Dr. McGarry is a Pediatric Pulmonologist who researches cystic fibrosis. Her main focus is researching health disparities in cystic fibrosis, particularly in minorities. She is conducting a cohort study of lung function in Latinos/Hispanics with cystic fibrosis. She also does research in diversity in clinical trials in cystic fibrosis.

Dr. McGarry studied Biology at Whitworth College. She then attended University of Washington School of Medicine, working in many underserved regions from Alaska to Zambia. She completed her Pediatric residency at Rainbow Babies and Children's Hospital. She completed her Pediatric Pulmonary and Pediatric Clinical Pharmacology Fellowships at University of California San Francisco. She also completed her Masters in Clinical Research at University of California San Francisco.

Interests

Cystic Fibrosis, Health Disparities, Minority Inclusion In Clinical Trials, Diversity In Research, Hispanic Latino Health, Pediatric Lung Diseases, Health Equality, Clinical Pharmacology, Asthma, Cystic Fibrosis Transmembrane Conductance Regulator, Personalized Medicine, Lung Function, Pulmonary Function, Cystic Fibrosis Related Diabetes, N of 1 Study

Websites

	Center for Latinos With Cystic Fibrosi
	Dr. McGarry's Clinical Page

In The News

	KTVU Interview About Trikafta (11/05/2019)
	Long-awaited cystic fibrosis drug could turn deadly disease into a manageable condition (10/31/2019)
	Rare Mutations Drive Cystic Fibrosis in Caribbean (10/30/2019)
	After big gains, Cystic Fibrosis Foundation bankrolls research toward cures — and drugs for those left out (10/30/2019)
	Rare Cystic Fibrosis Mutations Dominate in Caribbean Patients (10/30/2019)
	Tackling the Misconception That Cystic Fibrosis Is a "White People's Disease" (05/26/2021)
	Work in Progress on Challenges of Minority Representation in CF Trials (7/20/2021)

Research Activities and Funding

Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis
NIH K23HL133437Feb 1, 2018 - Jun 30, 2023
Role: Principal Investigator

Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis
Cystic Fibrosis Foundation Jul 1, 2016 - Jun 30, 2019
Role: Primary Investigator

Ivacaftor in non-G551D cystic fibrosis patients
Cystic Fibrosis Foundation, Research Development Program Grant May 1, 2013 - Apr 30, 2015
Role: Co-Investigator

Clinical Pharmacology, Drug Action and Pharmacogenetics
NIH T32GM007546Jul 1, 1977 - Jun 30, 2025
Role: Co-Investigator

Featured Publications

Twitter

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype. Pediatr Pulmonol. 2021 Jun; 56(6):1496-1503. McGarry ME, McColley SA. PMID: 33470563.

View in: PubMed Mentions: 1 Fields:
Ped Pediatrics Pul Pulmonary Medicine
Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States. J Cyst Fibros. 2021 May; 20(3):424-431. McGarry ME, Huang CY, Nielson DW, Ly NP. PMID: 33162303.

View in: PubMed Mentions: Fields:
Pul Pulmonary Medicine
Outcomes of Children With Cystic Fibrosis Admitted to PICUs. Pediatr Crit Care Med. 2020 10; 21(10):e879-e887. Smith MA, McGarry ME, Ly NP, Zinter MS. PMID: 32304511.

View in: PubMed Mentions: Fields:
Cri Critical Care Ped Pediatrics
Translation:Humans
Transparency and diversity in cystic fibrosis research. Lancet. 2020 08 29; 396(10251):601. McGarry M. PMID: 32861304.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)
Translation:Humans
Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation. N Engl J Med. 2020 02 13; 382(7):684. McGarry ME. PMID: 32053310.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)
Translation:Humans
The demographics of adverse outcomes in cystic fibrosis. Pediatr Pulmonol. 2019 11; 54 Suppl 3:S74-S83. McGarry ME, Williams WA, McColley SA. PMID: 31715087.

View in: PubMed Mentions: 3 Fields:
Ped Pediatrics Pul Pulmonary Medicine
Translation:Humans
Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico. Pediatr Pulmonol. 2020 02; 55(2):533-540. Zeiger AM, McGarry ME, Mak ACY, Medina V, Salazar S, Eng C, Liu AK, Oh SS, Nuckton TJ, Jain D, Blackwell TW, Kang HM, Abecasis G, Oñate LC, Seibold MA, Burchard EG, Rodriguez-Santana J. PMID: 31665830.

View in: PubMed Mentions: 1 Fields:
Ped Pediatrics Pul Pulmonary Medicine
Translation:Humans Cells
Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States. Pediatr Pulmonol. 2019 09; 54(9):1382-1390. McGarry ME, Neuhaus JM, Nielson DW, Ly NP. PMID: 31144477.

View in: PubMed Mentions: 3 Fields:
Ped Pediatrics Pul Pulmonary Medicine
Translation:Humans
Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children. Clin Infect Dis. 2019 05 17; 68(11):1847-1855. Zinter MS, Dvorak CC, Mayday MY, Iwanaga K, Ly NP, McGarry ME, Church GD, Faricy LE, Rowan CM, Hume JR, Steiner ME, Crawford ED, Langelier C, Kalantar K, Chow ED, Miller S, Shimano K, Melton A, Yanik GA, Sapru A, DeRisi JL. PMID: 30239621.

View in: PubMed Mentions: 20 Fields:
Com Communicable Diseases
Translation:Humans Animals Cells
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma. Pharmacogenomics J. 2019 06; 19(3):249-259. Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC, Serebrisky D, Lenoir MA, Brigino-Buenaventura E, Cintron WR, Thyne SM, Rodriguez-Santana JR, Ford JG, Chapela R, Estrada AM, Sandoval K, Seibold MA, Winkler CA, Bleecker ER, Myers DA, Williams LK, Hernandez RD, Torgerson DG, Burchard EG. PMID: 30206298.

View in: PubMed Mentions: 15 Fields:
Mol Molecular Biology Pha Pharmacology
An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos. J Allergy Clin Immunol. 2019 03; 143(3):957-969. Gignoux CR, Torgerson DG, Pino-Yanes M, Uricchio LH, Galanter J, Roth LA, Eng C, Hu D, Nguyen EA, Huntsman S, Mathias RA, Kumar R, Rodriguez-Santana J, Thakur N, Oh SS, McGarry M, Moreno-Estrada A, Sandoval K, Winkler CA, Seibold MA, Padhukasahasram B, Conti DV, Farber HJ, Avila P, Brigino-Buenaventura E, Lenoir M, Meade K, Serebrisky D, Borrell LN, Rodriguez-Cintron W, Thyne S, Joubert BR, Romieu I, Levin AM, Sienra-Monge JJ, Del Rio-Navarro BE, Gan W, Raby BA, Weiss ST, Bleecker E, Meyers DA, Martinez FJ, Gauderman WJ, Gilliland F, London SJ, Bustamante CD, Nicolae DL, Ober C, Sen S, Barnes K, Williams LK, Hernandez RD, Burchard EG. PMID: 30201514.

View in: PubMed Mentions: 12 Fields:
All Allergy and Immunology
Translation:Humans Cells
Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatr Pulmonol. 2017 Dec; 52(12):1550-1557. McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP. PMID: 29082671.

View in: PubMed Mentions: 7 Fields:
Ped Pediatrics Pul Pulmonary Medicine
Translation:Humans
In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies. Pediatr Pulmonol. 2017 04; 52(4):472-479. McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW. PMID: 28068001.

View in: PubMed Mentions: 13 Fields:
Ped Pediatrics Pul Pulmonary Medicine
Translation:Humans
Breastfeeding associated with higher lung function in African American youths with asthma. J Asthma. 2017 Oct; 54(8):856-865. Oh SS, Du R, Zeiger AM, McGarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Eng C, Nishimura KK, Huntsman S, Farber HJ, Meade K, Avila P, Serebrisky D, Bibbins-Domingo K, Lenoir MA, Ford JG, Brigino-Buenaventura E, Rodriguez-Cintron W, Thyne SM, Sen S, Rodriguez-Santana JR, Williams K, Kumar R, Burchard EG. PMID: 27929698.

View in: PubMed Mentions: 2 Fields:
All Allergy and Immunology Pul Pulmonary Medicine
Translation:Humans
Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis. Ann Am Thorac Soc. 2016 10; 13(10):1721-1725. McGarry ME, McColley SA. PMID: 27410177.

View in: PubMed Mentions: 12 Fields:
Pul Pulmonary Medicine
Translation:Humans
Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest. 2015 Jun; 147(6):1591-1598. McGarry ME, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne SM, Sen S, Rodriguez-Santana JR, Borrell LN, Burchard EG. PMID: 25742612.

View in: PubMed Mentions: 26 Fields:
Pul Pulmonary Medicine
Translation:Humans
The lung corps' approach to reducing health disparities in respiratory disease. Ann Am Thorac Soc. 2014 May; 11(4):655-60. Thakur N, McGarry ME, Oh SS, Galanter JM, Finn PW, Burchard EG, ATS Health Equality Committee . PMID: 24697756.

View in: PubMed Mentions: 4 Fields:
Pul Pulmonary Medicine
Translation:Humans
Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N. Chest. 2013 Oct; 144(4):e1-e4. McGarry ME, Nielson DW. PMID: 24081349.

View in: PubMed Mentions: 7 Fields:
Pul Pulmonary Medicine
Translation:Humans

Meghan McGarry, MD, MS